SYVC

Healthcare Biotechnology

Synovics Pharmaceuticals, Inc.

$0.00
-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap
542,857.986
Avg Volume
0
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%

Valuation

P/B Ratio
-0.00
P/S Ratio
0.03
EV/EBITDA
-1.88
EV/Revenue
0.36

Margins

Gross Margin 23.4%
Operating Margin (117.8%)
Net Margin (26.4%)
EBITDA Margin (19.1%)

Growth & Returns

Revenue Growth (YoY)
(79.5%)
Return on Equity
(314.3%)
Return on Assets
(12.7%)

Liquidity & Leverage

Current Ratio
0.27
Quick Ratio
0.10
Total Cash
129,860
Total Debt
6.15M

About

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.